Updated: IDSA Guidelines on the Treatment and Management of Patients with COVID-19
23 Jun, 2020 | 08:45h | UTC
IDSA has just released updates to its COVID-19 Treatment and Management Guidelines. New recommendations have been made on the use of #remdesivir, #hydroxychloroquine, hydroxychloroquine + #azithromycin, #convalescentplasma for treatment & #famotidine. ? https://t.co/H4KGct57fZ pic.twitter.com/hUuU1aYS4r
— IDSA (@IDSAInfo) June 23, 2020